Skip to main content
Veterinary Medicines

Felicam 2.5 mg chewable tablets for dogs

Authorised
  • Meloxicam

Product identification

Medicine name:
Felicam 2.5 mg chewable tablets for dogs
Felicam 2,5 mg tyggetabletter
Active substance:
  • Meloxicam
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Meloxicam
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AC06
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Cardboard boxes containing 10 tablets in Alu/Alu blisters.
  • Cardboard boxes containing 7 tablets in Alu/Alu blisters.
  • Cardboard boxes containing 84 tablets in Alu/Alu blisters.
  • Cardboard boxes containing 100 tablets in Alu/Alu blisters.
  • Cardboard boxes containing 252 tablets in Alu/Alu blisters.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Felix Pharmaceuticals Private Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wasdell Europe Limited
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 65313
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/0143/002
Concerned member states:
  • Belgium
  • Denmark

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."